-
Track & Monitor
Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals – August 2020
GlobalData's “Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals - August 2020” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2020. The report portrays detailed comparative data on the number of deals and their value in the...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in December 2017. The industry reported 375 deals worth USD21 billion in December 2017, compared to 403 deals worth USD27.5 billion in November 2017. The oncology therapeutics market remained at the top in deal activity in December 2017 with 124 deals. In second place, central nervous system therapeutics market reported 77 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2017
The pharmaceutical and healthcare industry reported an increase in the number of deals and a decline in deal values in Q4 2017 with 1,249 deals worth USD82.8 billion, as compared 1,197 worth USD94.7 billion in Q4 2016. On a quarter-on-quarter basis, the number of deals increased and deal values decreased in Q4 2017, when compared to 1,156 deals worth USD91.3 billion in Q3 2017. The pharmaceutical and healthcare industry reported a decrease in upfront payments in licensing agreements with USD794.5m...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2018. The report portrays detailed comparative data on the number of deals and their value in the last...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for February 2018 in Pharmaceuticals
The pharmaceutical and healthcare industry reported an increase in the number of deals and deal values in February 2018. The industry reported 413 deals worth USD50.9 billion in February 2018, compared to 410 deals worth USD26.7 billion in January 2018. The oncology therapeutics market remained at the top in deal activity in February 2018 with 110 deals. In second place, infectious disease therapeutics market reported 68 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront payments....
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry recorded a marginal increase in the number of number deals and a decrease in deal values in 2017 with 4,840 deals worth USD362 billion, as compared to 4,838 deals worth USD404.9 billion in 2016. The oncology market recoded 1,654 deals in 2017, as compared to 1,596 deals in 2016. North America recorded a decrease in the number of deals and deal values with 3,040 deals worth USD225.8 billion in 2017, as compared to 3,148 deals...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2018
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q1 2018. The report portrays detailed comparative data on the number of deals and their value in the last...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2018 in Pharmaceuticals
The pharmaceutical and healthcare industry reported an increase in the number of deals and deal values in January 2018. The industry reported 413 deals worth USD50.9 billion in January 2018, compared to 410 deals worth USD26.7 billion in December 2017. The oncology therapeutics market remained at the top in deal activity in January 2018 with 148 deals. In second place, central nervous system therapeutics market reported 99 deals. Licensing agreements in pharmaceutical and healthcare industry registered a decrease in upfront...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for July 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in July 2017. The industry reported 314 deals worth USD29.5 billion in July 2017, compared to 392 deals worth USD31.5 billion in June 2017. The oncology therapeutics market remained at the top in deal activity in July 2017 with 104 deals. In second place, infectious disease therapeutics market reported 60 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront payments....
-
Analyst Opinions
Best Practices in Retail: Cloud Computing
"Best Practices in Retail: Cloud Computing", report analyzes the latest developments in retailers' cloud strategies and their challenges. Cloud technology provides scalability, flexibility and agility to deploy advanced computing capacity at lower cost than traditional data centers. The report analyzes multiple best practice approaches from different retailers in order to assist in finding the most appropriate solution. Cloud computing technology provides the ability to centralize management of fragmented retail operations on a single platform. Unlike traditional IT systems and solutions,cloud...